Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 24, 2024Canadian Journal of Neurological Sciences / Journal Canadien des Sciences NeurologiquesOpen Access

F.3 Multicentre prospective validation of integrated molecular classification of meningiomas and prediction of recurrence risk using DNA methylation

View Full Paper
Ask AI
Bookmark
Share

Authors

JWJZ WangVPV PatilALAP Landry

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wang et al. (2024) studied this question.

synapsesocial.com/papers/68e6898eb6db643587611d1ahttps://doi.org/10.1017/cjn.2024.105
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A framework for using DNA methylation-based modelling for the clinical management of cranial meningioma2025
  2. 2Development, validation, and utility of a clinically applicable methylation classifier for recurrence risk prediction in meningiomas2025
  3. 3Clinical implications of DNA methylation-based integrated classification of histologically defined grade 2 meningiomas2024 · 9 citations
  4. 4379 Meningioma Molecular Groups Predict Response to Adjuvant Radiotherapy Following Surgery2024
  5. 5Prognostic impact of radiotherapy timing in WHO grade 2 and 3 meningiomas utilizing an integrated molecular-morphologic classification2026